Ursula Kassner

Berlin, BE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Comparative efficacy and safety of olezarsen versus volanesorsen for familial chylomicronemia syndrome: a matching-adjusted indirect comparison.

Comparative efficacy and safety of olezarsen versus volanesorsen for familial chylomicronemia syndrome: a matching-adjusted indirect comparison.

Journal: Journal of comparative effectiveness research

Published: June 19, 2026

Impact of Lipoprotein (a) on the Quantification of LDL-Cholesterol.

Impact of Lipoprotein (a) on the Quantification of LDL-Cholesterol.

Journal: Clinical laboratory

Published: May 20, 2026

Improved diagnosis of familial hypercholesterolemia by correcting LDL-C for lipoprotein(a) in a German cohort.

Improved diagnosis of familial hypercholesterolemia by correcting LDL-C for lipoprotein(a) in a German cohort.

Journal: Journal of clinical lipidology

Published: December 15, 2025

Evinacumab Treatment of Homozygous Familial Hypercholesterolemia Patients in a Real-World Setting: An Overview After the First Year of Therapy.

Evinacumab Treatment of Homozygous Familial Hypercholesterolemia Patients in a Real-World Setting: An Overview After the First Year of Therapy.

Journal: AACE endocrinology and diabetes

Published: November 25, 2025

Inclisiran-based treatment strategy in hypercholesterolaemia: the VICTORION-difference trial.

Inclisiran-based treatment strategy in hypercholesterolaemia: the VICTORION-difference trial.

Journal: European heart journal

Published: July 30, 2025

One-year treatment trajectories of patients with statin intolerance: results from a multicentre registry.

One-year treatment trajectories of patients with statin intolerance: results from a multicentre registry.

Journal: European journal of preventive cardiology

Published: July 07, 2025

Self-medication to lower LDL cholesterol and to treat statin-associated muscle symptoms in patients with statin intolerance.

Self-medication to lower LDL cholesterol and to treat statin-associated muscle symptoms in patients with statin intolerance.

Journal: Journal of clinical lipidology

Published: March 30, 2025

Design and rationale of the VICTORION-Difference study: A phase 4 randomized, double-blind, placebo-controlled clinical trial to assess inclisiran's early efficacy, safety, tolerability, as well as its impact on quality of life in individuals with hypercholesterolemia.

Design and rationale of the VICTORION-Difference study: A phase 4 randomized, double-blind, placebo-controlled clinical trial to assess inclisiran's early efficacy, safety, tolerability, as well as its impact on quality of life in individuals with hypercholesterolemia.

Journal: American heart journal

Published: February 20, 2025

Evaluation of current indirect methods for measuring LDL-cholesterol.

Evaluation of current indirect methods for measuring LDL-cholesterol.

Journal: Clinical chemistry and laboratory medicine

Published: January 08, 2025

Treatment strategies and LDL cholesterol target attainment in patients with statin intolerance: Insights from the multicentre statin intolerance registry.

Treatment strategies and LDL cholesterol target attainment in patients with statin intolerance: Insights from the multicentre statin intolerance registry.

Journal: American journal of preventive cardiology

Published: November 21, 2024

Quality of life in patients with statin intolerance: a multicentre prospective registry study.

Quality of life in patients with statin intolerance: a multicentre prospective registry study.

Journal: The Lancet regional health. Europe

Published: April 25, 2024

Changing from lipoprotein apheresis to evolocumab treatment lowers circulating levels of arachidonic acid and oxylipins.

Changing from lipoprotein apheresis to evolocumab treatment lowers circulating levels of arachidonic acid and oxylipins.

Journal: Atherosclerosis plus

Published: September 20, 2023

Showing 1-12 of 53

Last Updated: 09/26/2026